April 23, 2025Open Access

Advancing Cancer Treatment: A Review of Immune Checkpoint Inhibitors and Combination Strategies

Key Points

Key points are not available for this paper at this time.

Abstract

A groundbreaking milestone in oncology has been the recognition and targeted elimination of malignant cells through cancer immunotherapy, which harnesses the body’s immune system to attack cancer ...

Read Full Paperexternally

اسأل الذكاء الاصطناعي

Bookmark

View Full Paper

Cite This Study

Neil et al. (Wed,) studied this question.

synapsesocial.com/papers/695bff150477f73b29cc85a0 https://doi.org/https://doi.org/10.3390/cancers17091408

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1The Intriguing History of Cancer Immunotherapy2019 · 450 citations
2Immune Monitoring in Melanoma and Urothelial Cancer Patients Treated with Anti-PD-1 Immunotherapy and SBRT Discloses Tumor Specific Immune Signatures2021 · 6 citations
3IMpower150 Final Overall Survival Analyses for Atezolizumab Plus Bevacizumab and Chemotherapy in First-Line Metastatic Nonsquamous NSCLC2021 · 526 citations
4An Exploration of Oral-Gut Pathogens Mediating Immune Escape of Pancreatic Cancer via miR-21/PTEN Axis2022 · 33 citations
5Efficacy of immune-checkpoint inhibitors combined with cytotoxic chemotherapy in advanced or recurrent endometrial cancer: A systematic review and meta-analysis2024 · 12 citations

اسأل الذكاء الاصطناعي

Bookmark

View Full Paper